We accelerate drug development and personalized medicine for arthritis using disease-on-a-chip model
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Vienna
State: Wien
Zip:
Country: Austria
At Pregenerate, we use scaleable organ-on-a-chip models to replace animal testing in pharmaceutical research for arthritis treatments. This enables pharmaceutical companies to save billions of dollars and improve the success rates of their drugs to market, in part because we can use human cells in our model.Ultimately, this same technology will allow us to stratify patients into targeted treatment subgroups, and even to tell each clinical patient what the best treatment is for his or her specific arthritis needs directly.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2019 | Pre Seed Round | 1 | $130k |
SOSV SOSV |
6/2022 | Convertible Note | 1 | - |
SOSV SOSV |
10/2020 | Seed Round | 2 | - |
RebelBio SOSV RebelBio SOSV |
5/2021 | Seed Round | 1 | - |
SOSV SOSV |
6/2022 | Convertible Note | 1 | - |
SOSV SOSV |
5/2021 | Seed Round | 1 | - |
SOSV SOSV |
10/2020 | Seed Round | 2 | - |
RebelBio SOSV RebelBio SOSV |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|